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Chitosan is widely investigated for biomedical applications due to its excellent 
properties, such as biocompatibility, biodegradability, bioadhesivity, antibacterial, etc. In 
the field of neural engineering, it has been extensively studied in forms of film and 
hydrogel, and has been used as scaffolds for nerve regeneration in the peripheral nervous 
system and spinal cord. One of the main issues in neural engineering is the incapability of 
neuron to attach on biomaterials. The present study, from a new aspect, aims to take 
advantage of the bio-adhesive property of chitosan to develop chitosan-based materials 
for neural engineering, specifically in the fields of brain repair and neuroprosthetics. 
Neuronal responses to the developed biomaterials will also be investigated and discussed. 
In the first part of this study (Chapter II), chitosan was blended with a well-
studied hydrogel material (agarose) to form a simply prepared hydrogel system. The 
stiffness of the agarose gel was maintained despite the inclusion of chitosan. The 
structure of the blended hydrogels was characterized by light microscopy and scanning 
electron microscopy. In vitro cell studies revealed the capability of chitosan to promote 
neuron adhesion. The concentration of chitosan in the hydrogel had great influence on 
neurite extension. An optimum range of chitosan concentration in agarose hydrogel, to 
enhance neuron attachment and neurite extension, was identified based on the results. A 
“steric hindrance” effect of chitosan was proposed, which explains the origin of the 
morphological differences of neurons in the blended gels as well as the influence of the 
physical environment on neuron adhesion and neurite outgrowth. This chitosan-agarose 
(C-A) hydrogel system and its multi-functionality allow for applications of simply 
prepared agarose-based hydrogels for brain tissue repair. 
In the second part of this study (Chapter III), chitosan was blended with graphene 
to form a series of graphene-chitosan (G-C) nanocomposites for potential neural interface 
applications. Both substrate-supported coatings and free standing films could be prepared 
by air evaporation of precursor solutions. The electrical conductivity of graphene was 
maintained after the addition of chitosan, which is non-conductive. The surface 
characteristic of the films was sensitively dependent on film composition, and in turn, 
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influenced neuron adhesion and neurite extension. Biological studies showed good 
cytocompatibility of graphene for both fibroblast and neuron. Good cell-substrate 
interactions between neurons and G-C nanocomposites were found on samples with 
appropriate compositions. The results suggest this unique nanocomposite system may be 
a promising substrate material used for the fabrication of implantable neural electrodes.  
 Overall, these studies confirmed the bio-adhesive property of chitosan. More 
importantly, the developed chitosan-based materials also have great potential in the fields 
of neural tissue engineering and neuroprosthetics. 
  vi
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1.1 Chitosan  
 Chitosan is a naturally occurring linear polysaccharide derived from chitin by 
deacetylation of the N-acetyl-glucosamine residues under alkaline conditions or by enzymatic 
hydrolysis in the presence of a chitin deacetylase.1 It is widely investigated for numerous 
applications in the life sciences, including cosmetics, dietetics, pharmacology, and biomaterials.2 
The chemical structure of chitosan largely determines its physical properties and applications. In 
this section, the structure-properties relationship of chitosan in solutions will be briefly 
introduced and discussed. Its applications in biomedical fields will then be elucidated. 
1.1.1 Structure-Properties Relationship 
  Fig. 1.1 shows the chemical structure of chitosan. Because the temperatures of glass 
transition and melting of chitosan are higher than its temperature of thermal decomposition, the 
fabrication of chitosan is necessarily processed from solutions.2 Therefore, the most important 
physical state for this polymer is solution. When studying solutions of chitosan, one of the key 
parameters need to be considered is the degree of deacetylation (DDA), which distinguishes 
chitosan from chitin. Molecular weight (MW) also plays critical roles for the properties of 
chitosan in solutions. 
1.1.1.1 Role of DDA 
 When DDA is higher than 40%, the polymer is soluble in dilute acidic solutions and is 
defined as chitosan. This behavior is associated to the fact that the protonated amine groups of 
glucosamine residues in acidic solutions interrupt the intrachain hydrogen bonds and make 
solvent/polymer interactions more favorable.2 The value of the intrinsic pKa of chitosan is found 
to be close to 6.5 when DDA is higher than 75%. That is, chitosan with DDA value higher than 
75% is soluble in a solution with a pH value lower than 6.5, ignoring the effects from MW. The 
relation between DDA and pKa of chitosan is quite complicated and requires a good 
understanding of polymer science. Readers are encouraged to refer to the extensive work from 
Sorlier et al. for more details.3 In this study, we are mainly concerned about the fact that a certain  
  2
 
Figure 1.1 Chemical structure of chitosan. 
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amount of acid is required to solubilize chitosan in water, which is the most preferred solvent for 
biomedical applications.  
1.1.1.2 Role of MW 
 Thermodynamics suggests a decreased solubility of neutral polymers with an increase of 
MW.4 In the case of chitosan, the possibility of intrachain association by hydrogen bonding plays 
an additional role.2 When MW increases, aggregation between polymer chains becomes 
favorable and the ionic strength becomes sufficiently high to favor the condensation of the 
counterions. In addition to the intrachain association, an increase in MW always results in an 
increase in viscosity of the solution. Therefore, it is often difficult to prepare chitosan solutions 
with a concentration above 2-3 wt%. Furthermore, decreasing the MW could potentially increase 
the concentration of the solution and improve the solubility of the polymer.  
1.1.2 Biomedical Applications 
 Chitosan has been extensively studied as a biomaterial due to its excellent properties, 
such as biocompatibility and biodegradability. For biomedical applications, it can be fabricated 
into a variety of forms, including hydrogels, films, fibers, sponges, and micro- / nano-particles.2 
 Tissue scaffold is one of the most important applications of chitosan. By crosslinking 
chitosan with glycerophosphate, Chenite et al. successfully prepared thermally sensitive neutral 
chitosan solutions based on chitosan/polyol salts.5 The solutions can gel at physiological 
temperature, and are able to deliver biologically active growth factors in vivo and serve as an 
encapsulating matrix for living chondrocytes for tissue engineering applications. Subsequent 
works using similar techniques have also been able to achieve a thermoresponsive system.6-9 In 
the form of film, chitosan can be fabricated into conduit and used as a tissue scaffold.10 Artificial 
poly(glycolic acid)-chitosan tube coated with recombinant L1-Fc promotes axonal regeneration 
and remyelination, and has been shown capable of guiding nerve regeneration.11 
 Drug/protein/gene delivery is an important domain where chitosan micro-/nano-particles 
are extensively employed. The positively charged chitosan chains can be easily complexed with 
negatively charged DNAs and proteins.12 A simple precipitation process to prepare chitosan 
microparticles without using any organic solvent was developed by Berthold et al.13 By simply 
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adding sodium sulfate (precipitant) into chitosan solution, the authors successfully prepared 
chitosan microparticles with size around 1 μm. The drug release behavior of the microparticles 
was tested in vitro using side-by-side diffusion cells and up to 30.5% loading was achieved with 
prednisolone sodium phosphate. The most widely used precipitant for the formation of chitosan 
nanoparticles is tripolyphosphate (TPP).12, 14, 15 Typically, a size ranging from 100 nm to 250 nm 
is suitable for the delivery of gene or protein macromolecules. In order to fabricate chitosan 
nanoparticles with predetermined properties, variations in chitosan molecular weight, chitosan 
concentration, the weight ratio of chitosan to TPP, and solution pH value were examined 
systematically for their effects on the particle size, intensity of surface charge, and tendency of 
particle aggregation.12 The authors also examined the particle morphology using transmission 
electron microscope (TEM) and confirmed a semicrystallization mechanism during the particle 
formation and growth, which could bear important implications on gene/protein encapsulation 
and release mechanisms. 
 Other biomedical applications of chitosan include surface modification, dialysis 
membrane, sutures, etc.1 Table 1.1 summarizes the main applications of chitosan in the field of 
biomaterials. Table 1.2 lists the important properties of chitosan related to biomedical 
applications.  
1.2 Neural Engineering   
 Neural engineering is a discipline that uses engineering techniques to understand, repair, 
replace, enhance, or treat the diseases of nervous systems. Due to its biological and engineering 
nature, many other disciplines are involved in its development, such as computational 
neuroscience, experimental neuroscience, clinical neurology, electrical engineering and signal 
processing, robotics, cybernetics, computer engineering, neural tissue engineering, materials 
science, and nanotechnology.16 In the present study, we will mainly focus on the two major 
domains in neural engineering: neural tissue engineering and neuroprosthetics. For tissue 
engineering, our work specifically aims to address problems encountered in brain repair. 
  Traumatic brain injury (TBI) occurs when an external physical insult causes damages in 
the brain. Because the injury is an on-going process, the primary damage could lead to a cascade  
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Table 1.1 Main applications of chitosan as biomaterials.1 
 
Form  Application  Route of delivery/properties  
Beads  Drug delivery Enzyme immobilization  Oral 
Micro-
spheres   Oral, implantable, ocular, injectable  
Coatings  Surface modification Textile finishes  
Chitosan increases mucoadhesivity of alginate capsules 
 
Fibers  Medical textiles Sutures  
 
Biodegradable  
Nano-fibers  Guided bone regeneration Scaffold for nerve tissue regeneration   
Films  Wound care Dialysis membrane   
Powder  
Adsorbent for pharmaceutical and medical devices 
Surgical glove powder 
Enzyme immobilization   
Sponge  
Mucosomal haemostatic dressing 
Wound dressing 
Drug delivery 











Anti-tumour agent  
Moisture holding 
Oral, nasal 




Tissue engineering   
Tablets  Compressed diluent Disintegrating agent  
Oral, buccal 
 
Capsules  Delivery vehicle  
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Table 1.2 Main properties of chitosan in biomedical applications.1 
Properties 
Biodegradability Antibacterial Renewable 
Biocompatibility Immunoadjuvant Absorption promotes 
Bioadhesivity Antithrombogenic Non-toxicity 
Polycationic substance Film forming Non-allergenic 
Antifungal Hydrating agent Anticholesteremic agent 
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of deleterious events that can affect cell body and axonal function, resulting in continued 
dysfunction and prolonged degeneration. Therefore, patients often suffer not only from the 
immediate post-injury complications, but also the long-term problems associated with TBI, such 
as Parkinson’s disease, Alzheimer’s diseases, post-traumatic dementia, etc.17 Fig. 1.2 shows the 
events following TBI, involving a dynamic interplay between events promoting neural repair and 
regeneration, and those of damage and inhibition.18 A better understanding of the mechanisms on 
both sides of the response can aid in the development of more effective clinical treatments for 
TBI. Each year, there are about 1.4 million people in the United States experience a TBI.17 As 
one of the leading causes of death and disability, TBI poses a staggering financial burden to the 
society, with an estimated expense of over $56 billion per year for medical care. Therefore, it is 
urgent to develop clinically effective treatments to alleviate the pains of both patients and the 
society. 
1.2.1 Neural Tissue Engineering 
 The main on-going researches for neuroprotection and neuroregeneration in injured 
central nervous system (CNS) include tissue scaffold, cell transplantation, and drug delivery.19 
Fig. 1.3 shows a scheme of the combination of these three approaches applied in brain repair. An 
artificial tissue scaffold can be implanted into the damaged region in the brain tissue, serving as a 
structural support to the surrounding tissue to minimize secondary cellular degeneration. Both 
neural stem cells and drugs can be delivered by the scaffold. Patient’s neurons from the adjacent 
parenchyma can also infiltrate the scaffold, which potentially promotes local tissue regeneration. 
 Because the scaffold is the platform for the delivery of cell and drug as well as neuron 
regeneration, its properties are critical to achieve all of these functions. The scaffold should 
provide a friendly environment for both resident neurons and implanted neurons by mimicking 
some of the features of the natural extracellular matrix (ECM) in the neural tissue. It should be 
neuron-adhesive to offer anchorage points that allow neuron adhesion and neurite outgrowth. It 
should be permissive, allowing cell migration and tissue remodeling as well as the diffusion of 
nutrients, metabolites, and soluble factors. The mechanical properties should match the brain 
tissue, because study has shown the mechanical properties of biomaterials are critical for neuron 
adhesion and neurite outgrowth.20 Biodegradability is favored for brain repair since no foreign  
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Figure 1.2 Schematic of events following traumatic brain injury (TBI): (blue boxes) damage and 
inhibition of regeneration; (orange boxes) permissive and reparative mechanisms. A better understanding 
of the mechanisms on both sides of the response can aid in the development of more effective clinical 
treatments for traumatic injury to the CNS.18 
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Figure 1.3 Combination of tissue scaffold, cell transplantation and drug delivery for the repair of 
damaged brain tissue. Adapted from reference Nature Review Neuroscience 10 (2009) 682-692.19  
Delivered drug 
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substance will remain in the injury site once new tissues have formed in place. When being used 
for drug delivery, the chemical and structural properties of the scaffold also need to be 
optimized. 
 Hydrogels have been favored as tissue scaffold materials for their excellent properties. 
The porous structure allows for infiltration of cells as well as the diffusion of drugs, gases, 
nutrients, and waste products. The mechanical properties of hydrogels can be tuned by changing 
the density of the crosslinking points, allowing low interfacial tensions between the scaffold and 
human tissue. Furthermore, most hydrogels are degradable by enzymes present in the human 
body, a desirable feature for brain repair.  
 Currently, hydrogels based on both natural (e.g., agarose, alginate, hyaluronan, etc.) and 
synthetic (e.g., polyethylene glycol, poly(2-hydroxyethyl methacrylate), etc.) polymers are being 
studied for neural engineering.21 One of the great limitations of these hydrogels is the need for 
chemically incorporation of neuron-adhesive protein or peptide sequences due to their intrinsic 
non-adhesive nature.22-24 Potential problems associated with chemical functionalization include: 
(1) complex, costly and time-consuming process and (2) introduction of toxic organic solvents 
during preparation that could be harmful for cellular growth. A simply prepared neuron-adhesive 
hydrogel system without any chemical reaction would have great potential for neural tissue 
engineering. 
1.2.2 Neuroprosthetics 
 Unlike neural tissue engineering, which aims to protect and repair the injured tissue right 
after the injury, neuroprosthetics are more like a “make-up” approach for a damaged nervous 
system. It generally involves artificial devices to replace the function of impaired nervous 
systems or sensory organs, such as restoring sights, hearing, movement, ability to communicate, 
and even cognitive functions. The most widely used neuroprosthetic device is the cochlear 
implant, which has been benefiting approximately 100,000 people worldwide as of 2006.25 
 Nowadays, chronically implanted neural electrodes recording signals from individual 
neurons in human brain rekindle the hope of numerous patients suffering from full or partial 
paralysis.26-28 Fig. 1.4 is a scheme showing the principle and potential applications of this kind of 
device as well as the greatest challenges it faces currently. The neural electrodes, which can be in  
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Figure 1.4 Principles, applications and challenge of implantable neural electrodes. 
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the form of metal wires or silicon and/or polymer shanks, are inserted into the brain cortex. If 
functioning properly, the device can record the action potentials from the adjacent healthy 
neurons. The collected signals are then transported to an external device, which typically is a 
computer. The signals are processed, analyzed, and translated into commands. Then the 
commands are utilized for controlling prosthetic devices, such as artificial arms, wheelchairs, 
entertainment media, etc.  
 To date, several different multichannel recording electrode arrays have been designed 
(Fig. 1.5).29-32 Most of them are fabricated from silicon taking advantage of the well-established 
manufacturing process used in the semiconductor industry. Although the present implant systems 
are well studied and perform as intended in short-term investigations, the greatest challenge of 
the implants for clinical applications is its unreliable long-term performance.33 For instance, a 
40% drop in the number of functional electrodes between 1 and 18 months was reported in the 
study of Nicolelis et al.29 Similar observations have also been reported by other researchers.31, 34   
 Scientific studies suggest that the long-term performance problem is likely due to the 
tissue response that the brain mounts against implanted electrodes.33 Several factors could 
potentially contribute to the tissue response: (1) the mechanical trauma of insertion severing 
capillaries, extracellular matrix, glial and neuronal cell processes; (2) the long-term inflammation 
induced by the presence of the insoluble device; (3) the biocompatibility of the implanted 
substrate material; and (4) the chronic micromotion-induced mechanical strains around the 
implant interface. Eventually, the response results in the formation of an encapsulating glial scar 
(Fig. 1.4) and a poor integration between the device and neural tissue.  
 Current approaches to minimize this tissue response include: (1) advanced neural probe 
design, (2) surface modification of the existing implanted substrate, and (3) drug delivery locally 
or systemically to therapeutically influence the cellular responses.33 A recent study from Dr. 
Kipke’s group at the University of Michigan reported the fabrication of a parylene-based probe 
with a thick shank and an integrated thin lateral platform with recording site.35 Biological studies 
showed a reduced tissue encapsulation and higher neuronal density around the recording site 
compared with the thick shank. It is suggested that the electrode performance can be maintained 
in long-term by attracting and preserving neurons near the recording sites. A variety of materials  
  13
 
Figure 1.5 Designs of multichannel recording electrode arrays: (a-b) wire electrode arrays;29 (c) a single 
electrode shank with multiple electrode sites;30 (d) Utah Electrode Array formed from a single block of 
silicon;31 (e-f) multiple planar arrays of Michigan Electrodes are stacked together to create a three-
dimensional array.32 
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have been used to modify the substrate surface, such as cell adhesion small polypeptides/proteins 
(e.g., poly-L-lysine and laminin36) and oligopeptides (e.g., Arg-Gly-Asp (RGD) and Tyr-Ile-Gly-
Ser-Arg (YIGSR)37). Conductive polymer coatings, including polypyrrole and poly(3,4-
ethylenedioxythiophene), have also been studied for their ability to overcome the encapsulation 
barrier and improve electrical characteristics by increasing electrode sensitivity.38-41 Drug release 
is another option that could potentially promote neuronal survival and growth. On the one hand, 
growth factors and chemoattractants can be used to attract neuron migration towards the 
electrodes and facilitate neuron regeneration.42 On the other hand, immunosuppressant molecules 
such as Dexamethasone43 and Cyclosporin-A44 can be used to reduce the initial immune response 
and potentially the glial scar formation. Other drugs like minocycline45-47 also show their 
capability to protect neurons against excitotoxicity by inhibiting activation and proliferation of 
microglia. Although moderate success has been achieved by some of the methods in reducing the 
tissue response, devices with long-term reliable performance are still not clinically applicable.  
 Simply modifying the surface of existing substrate materials will not be able to eliminate 
the micromotion induced by the mechanical mismatch between the tissue and electrodes, which 
is believed to profoundly contribute to the chronic immune response.33 Recently, the neural 
interface community is focusing on exploring brand new implantable materials that can be used 
for neural electrodes with reliable chronic performance.48 The new materials should be flexible 
with low interfacial tension with human brain and ability to change its shape along with tissue 
deformation. Electrical conductivity is required for the normal function of neural recording 
electrodes. The substrate should be neuro-adhesive to ensure good neuron-substrate interactions.  
In addition, good biocompatibility and biostability are always required for implantable 
biomaterials intended for chronic use. Developing substrate materials meeting all of these 
criteria is still a major challenge in the field of neuroprosthetics.   
1.3 Rationale and Objectives  
 Chitosan has been studied for nerve tissue regeneration. Until now, most of the works are 
focusing on its film and scaffold forms for nerve regeneration in the peripheral nervous system 
and spinal cord.6, 10, 49 The present study, from another aspect, aims to take advantage of the bio-
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adhesive property of chitosan and investigate its potential applications in neural engineering, 
specifically in the fields of brain repair and neuroprosthetics (brain-computer interface).  
 One of the main issues in neural engineering is the poor ability of neuronal cells to attach 
and grow on most biomaterials. A variety of strategies have been developed to stimulate neuron 
adhesion and growth.50 Scientific studies have shown that chemical factors (e.g., ECM proteins 
and certain peptide sequences51, 52), topographical features of biomaterials,53-55 and substrate 
stiffness play critical roles in neuron adhesion, growth, and tissue remodeling. Previous studies 
have shown the ability of chitosan to facilitate attachment of dorsal root ganglion (DRG),10, 56 
keratinocytes,57 fibroblasts,57 and Schwann cells,58 indicating a nonspecific interaction between 
cells and chitosan. Such characteristic could be attributed to the electrostatic attractive force 
between the positive charges of the protonated amine groups along chitosan chains and the 
negative charges of the phospholipid structure of the cell membrane. We propose that this bio-
adhesive property of chitosan could potentially improve neuron adhesion and neurite outgrowth, 
making chitosan a promising biomaterial candidate in the field of neural engineering.  
 In Chapter II, we simply blended chitosan with a well-studied hydrogel system (agarose). 
This hydrogel system showed good neuron-adhesive property. The concentration of chitosan also 
had great influence on neurite extension. A “steric hindrance” hypothesis was proposed to 
explain the observations in biological study. It implies that a proper adjustment of the blend 
composition could directly impact the morphological development of neurons, and could be used 
as a simple yet versatile approach to obtain desirable neuronal structures. The simplicity of 
preparing this hydrogel system also allows for future applications of agarose-based hydrogels for 
neural tissue repair. 
 In Chapter III, we developed a brand new graphene-chitosan nanocomposite system as a 
potential substrate material for implantable neural electrodes. The free standing film prepared 
by air evaporation showed good flexibility. The electrical conductivity of graphene was 
maintained after the incorporation of chitosan. Biological studies showed good biocompatibility 
of graphene and good cell-substrate interaction between neuron and G-C nanocomposites with 
proper compositions. The promising results indicated the potential impact of G-C 
nanocomposites on the clinical translation of neural interface technology by improving the long-
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lasting performance of the implant through fundamental changes of the substrate material used 
for implant fabrication. 
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CHAPTER II 
CHITOSAN-AGAROSE HYDROGELS FOR BRAIN REPAIR 
 An article presenting part of the results in this chapter has been published on 
Biomacromolecules [Zheng Cao, Ryan Gilbert, Wei He. Simple agarose-chitosan gel composite 
system for enhanced neuronal growth in three dimensions. Biomacromolecules 2009, 10 (10), 
2954-2959]. Published data include: Fig. 2.3, Fig. 2.4, Fig. 2.5 (a, d and g), Fig. 2.6, Fig. 2.7, 
Fig. 2.8, Fig. 2.9, Fig. 2.10, and Fig. 2.11.  Section 2.3.2, 2.3.3 and 2.4 are directly cited from the 
article with a few modifications. Section 2.1, 2.2 and 2.3.1 are newly written.  
 The first author (Zheng Cao) finished all of the experiments in this study. The third and 
corresponding author (Dr. Wei He) is advisor of Zheng Cao and financially supported this work. 
The second author (Dr. Ryan Gilbert) is a collaborator of Dr. Wei He, and gave professional 
advice on this work. 
2.1 Introduction 
 Chitosan itself can be fabricated into a three-dimensional (3D) hydrogel using salts or 
other agents. However, our preliminary data indicate that chitosan hydrogel is non-permissive for 
neural growth. A well studied hydrogel system, agarose, was selected as the hydrogel matrix for 
this study. Agarose, a biocompatible polysaccharide, is widely investigated as a 3D scaffold for 
neural engineering. In the form of a hydrogel, agarose has porous structure59 and provides a 
friendly environment for cellular spreading and proliferation.60, 61 The main issue for agarose to 
be used as a neural scaffold is its incapability to support cell attachment.62 Previous study has 
shown chemical functionalization of agarose with neuro-adhesive components could improve E9 
chick DRG neurite extension, but the complex chemical process is costly and time-consuming.60 
Here, we chose to blend chitosan into agarose hydrogel to simplify the preparation process and 
investigate its potential application for brain repair. The influences of chitosan on neuron 
adhesion and neurite extension were also studied. 
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2.2 Preliminary Study for Chitosan Selection 
2.2.1 Rationales 
 As mentioned earlier, the values of DDA and MW could affect the physical properties of 
chitosan. Currently, there are a variety of chitosan products available in the market, with 
different origins and chemical structures. Because it is not practical to perform the work using all 
types of chitosan, we need to indentify one most suited for the intended applications first. To 
avoid the influences from origin and processing, a series of chitosan from one vendor will be 
compared. Because characterization and modification of chitosan are not parts of this study, only 
products with known values of DDA and MW were considered. After a brief investigation, a 
series of chitosan (Sigma) with similar values of DDA (75% - 85%) but different MW (LMW: 
50,000-190,000 g/mol; MMW: 190,000-310,000 g/mol; HMW: 310,000-375,000 g/mol) were 
selected for preliminary study. Because chitosan with the same MW but different DDA are not 
readily available, the effect of DDA on neuron growth will not be considered here.  
 The three types of chitosan were generously provided by Dr. Kevin M. Kit (Department 
of Materials Science & Engineering, UTK) and Dr. Svetlana Zivanovic (Department of Food 
Science and Technology, UTK). Three chitosan-agarose (C-A) hydrogels with consistent 
concentration (both C and A: 1 wt%) were prepared. Plain agarose hydrogels (1 wt%) served as a 
control. Primary chick cortical neurons were cultured on the samples for 3 days and 
characterized using confocal microscopy. Hydrogel sample supporting the most neuron adhesion 
(i.e., highest cell density) and neurite outgrowth (i.e., best neural network) is considered as the 
premium substrate, and chitosan used for that sample will be employed for the rest of the study. 
Detailed procedures related to sample preparation and in vitro study are described in the 
following sections. 
2.2.2 Results & Conclusion 
  A drastic increase of cell number was observed on all C-A hydrogels (Fig. 2.1 (a) – (c)) 
compared with plain agarose hydrogel (Fig. 2.1 (d)), which confirms our hypothesis that 
chitosan could improve neuron adhesion. In addition, a better neural network was developed on  
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Figure 2.1 Neuron growth on C-A prepared with different types of chitosan: (a) LMW, (b) MMW, (c) 
HMW, and (d) plain agarose. Scale bar = 300 μm. 
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C-A hydrogel made from LMW chitosan (Fig. 2.1 (a)). Therefore, LMW chitosan was selected 
for the rest of the study. 
2.3 C-A Hydrogels for Brain Repair 
2.3.1 Rationales 
 This section briefly introduces the rationales behind the experimental design and special 
techniques used in this chapter. Please see section 2.3.2 Experiments for detailed experiments. 
2.3.1.1 Sample preparation 
 The concentration of chitosan is the only variable in sample preparation. As mentioned 
earlier, solutions with chitosan concentration above 3 wt% are not feasible due to the large 
increase in viscosity of the solution and the limited solubility of chitosan.2 Therefore, the 
concentration of chitosan was kept below 3 wt%. Acetic acid aqueous solution was used to 
dissolve chitosan. SeaPrep® agarose was selected according to a previous study60, and was 
kindly donated by Lonza Rockland. A consistent agarose concentration (1 wt%) was maintained 
for all the samples as this concentration of SeaPrep® agarose gel supported the best neurite 
outgrowth from chick DRG. Moderate heating (~60 °C) is required to dissolve this SeaPrep® 
agarose in water, and relatively low temperature (10 – 17 °C) is necessary for the solution to 
form a gel. Therefore, after plating final solutions in glass-bottom petri dishes, samples were 
kept in a refrigerator for gelation. Generally, all of the hydrogel compositions can gel within 20 
min at 4 °C. A rinse with basic phosphate buffered saline (PBS) was applied for all C-A 
hydrogels to neutralize the acid. For biological study, samples also need to be sterilized. A 20 
min UV exposure was utilized for sterilization as opposed to commonly used autoclave 
approach, considering the hydrating nature of the gel. 
2.3.1.2 Sample characterization 
 Because studies have shown the mechanical properties of a substrate have great influence 
on neuron adhesion and growth,20 the stiffness of the hydrogels was evaluated by a rheometer 
according to a previous study.63 The purpose of this measurement is to determine if the 
incorporation of chitosan influences the mechanical properties of agarose gel, thereby affecting 
the neuron adhesion and growth on C-A hydrogels.  
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 C-A hydrogels were as clear as plain agarose after gelation, but they turned into opaque 
after the basic rinse. Therefore, the structure of the hydrogels was characterized by light 
microscopy and scanning electron microscopy (SEM). The internal structure of the hydrogels 
was observed under a light microscope with oil lens for high magnification imaging. The surface 
structure of the samples was characterized by SEM. 
2.3.1.3 Primary cortical neuron culture 
 Instead of using neuron cell lines, primary chick cortical neuron was used for the in vitro 
study to better represent the neuronal responses in real brain tissue. According to our previous 
experience, primary cortical neurons are especially “picky” and can only attach on specially 
treated substrates (e.g., laminin coated petri dish). Failure in adhesion will eventually lead to cell 
death. Cortical neurons were harvested from the forebrain of a 9-day old chick embryo. To 
disaggregate the forebrain tissue, a combination of chemical and mechanical dissociation 
methods was utilized to prepare a suspension of single cells. Cell purification can be achieved by 
incubating the cell suspension on a collagen coating. This process has been reported to provide 
culture with 97% of neuron composition.64 It is worth noting that primary cortical neurons do not 
proliferate, which is different from commonly used neuron cell lines. Therefore, the number of 
neurons on substrates can only decrease due to cell death, but will not increase during culture. 
2.3.1.4 Fluorescent microscopy  
 Because the neutralized C-A hydrogels were opaque, the cell cultures on these samples 
could not be directly observed under a inverted light microscope. Accordingly, a live staining 
technique (Live/Dead Viability/Cytotoxicity Kit for mammalian cells, Invitrogen) was applied to 
enable cell emitting green fluorescence under a fluorescent microscope. The principle behind this 
method is that live cells can absorb the nonfluorescent staining agent (calcein AM) and 
enzymatically convert it into fluorescent calcein, while dead cells are unable to achieve the 
conversion. In this way, only cells survived during the culture will be detected under the 
fluorescent microscope. To save time, images at certain magnifications were taken for all 
cultures first and analyzed later. 
 Because agarose gel is a 3D permissive scaffold for cell growth, a laser scanning 
confocal fluorescent microscope was used to collect signals throughout the hydrogel. Confocal 
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microscopy offers several advantages over a conventional optical microscopy, including the 
ability to control depth of field, elimination or reduction of background information away from 
the focal plane, and the capability to collect serial optical sections from thick specimens.65 Fig. 
2.2 shows the principle of this technique. Using the software provided by the vendor, one 
composite image showing all the information from the serial sections is achievable. The signal 
can also be presented in different colors to show the 3D profile of the culture.  
2.3.1.5 Assessment of neuron responses to substrates 
 There are a number of ways for assessing cellular responses to substrates. Cell viability is 
the most commonly used one. By counting cell number on the substrate after a certain period of 
culture and comparing with a positive or negative control, the biocompatibility of the substrate 
can be evaluated. Plain agarose hydrogel was used as a control for this study because we would 
like to see if the incorporation of chitosan could improve the neuron-adhesive property of 
agarose hydrogel. To obtain quantitative results, the cell number within a defined area of a 
substrate is counted and used to calculate the cell density (cells/cm2). 
 How well can neurons differentiate on/within a substrate is another important criterion 
for neuron related study. For example, as shown in Fig. 1.3, the ultimate goal for neural tissue 
engineering is to build a good network among neuronal cells and realize their normal functions 
(signal transportation). The methods for assessing neurite outgrowth are well summarized by 
Radio and Mundy,66 including semi-quantitative, quantitative, and biochemical assessments. 
Each of these categories has their advantages and disadvantages (Table 2.1). For semi-
quantitative methods, the exact length of neurite will not be measured. It is only used for 
classifying cells into different groups, such as cells with neurites and cells without neurites. 
Therefore, the assessment can be simple and rapid, and no special technique or software is 
required. The results might be subjective, however, with a risk of scoring bias. Quantitative 
assessment, on the other hand, can be quite time-consuming and work-demanding if analysis is 
done by hands. Software could be employed for analysis, but it can be fairly expensive. 
Accuracy is the advantage of this kind of method. Neurite outgrowth can also be quantified using 
a variety of biochemical markers, based on the assumption that biomarkers correlate with both 
differentiation and increases in neurite length. Procedures, such as enzyme-linked  
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Figure 2.2 Principle of confocal microscopy.65 
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Table 2.1 Methods for assessment for neurite growth.  






Can be subjective 
Number of cell exhibiting neurites 
Percentage of cells exhibiting neurites 
Number of neurites per cell 
Quantitative  Accurate 
Time-consuming 
Greater amount of work 
Expensive  
Length of the longest neurite 
Total neurite length 
Average neurite length 
Biochemical  Rapid  
Costly 
There may not be a direct 
relationship between the 







immunosorbent assay (ELISA), immunoblotting, and proteomic techniques, are useful in high 
throughput screening. The measurement can be rapid, but the biochemical reagents used for 
marking neurites are often expensive. There is also a concern about the accuracy between the 
biomarker expression and the actual neurite length. Considering the availability of techniques 
and the cost of the assessments, a semi-quantitative method was selected for this study. Instead 
of just calculating the percentage of cells exhibiting neurites, we categorize cells into four groups 
according to the length of their longest neurite. Briefly, four different ranges of neurite length 
were predetermined, including 0 – 25 μm, 25 – 50 μm, 50 – 150 μm and >150 μm. Each cell on 
the substrate was classified into one of the four groups according to the length of its longest 
neurite. For example, if a neuron has four neurites and the longest one is 100 μm in length, this 
cell will be put into the 50 – 150 μm group. After all cells on one substrate were grouped, the 
percentage of cells exhibiting different length of neurites was calculated and compared.  
2.3.1.6 Statistical analysis 
 Statistical analysis is a very important technique in biological studies. Considering the 
randomness and unpredictable variability during sample preparation and data collection, 
repetition must be conducted before achieving any solid conclusion. In this study, all cultures 
were repeated three times, meaning that each sample was subjected to cultures on three separate 
days. A statistical software (SAS) was used for the data analysis. 
2.3.2 Experiments 
2.3.2.1 Preparation of C-A  
 A series of C-A hydrogels with chitosan content varying between 0 and 3 wt% were 
prepared following a simple procedure. Hydrogels with higher chitosan concentration beyond 3 
wt% are not feasible and reliable for cell culture work due to the large increase in the viscosity of 
the solution and the limited solubility of chitosan.2 Briefly, chitosan (LMW, Sigma) was first 
dissolved in a 2.5 wt% acetic acid solution. SeaPrep® agarose (Lonza) (1 wt%) was then added 
to the chitosan solution and dissolved by heating the mixture in a 60 °C water bath. To prepare 
hydrogels for cell culture, 100 μl of the final solution was plated in a glass bottom petri dish 
(well: 1.4 cm in diameter, MatTek), and stored in a 4 °C refrigerator overnight to ensure 
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complete gelation. Neutralization was achieved by extensive rinsing of the hydrogel with basic 
phosphate buffered saline (PBS) solution (pH = 8.5). Plain agarose hydrogels (1 wt%) were 
prepared as a control following a similar procedure, without the addition of acetic acid and 
neutralization. All hydrogels were sterilized in sterile PBS solution (pH = 7.4) by UV light 
exposure for 20 min before the cell culture. 
2.3.2.2 Rheological study of C-A  
 The mechanical stiffness of the hydrogel was determined by dynamic mechanical 
spectrometer (TA Instruments AR2000 rheometer, USA) at 37 °C with parallel plates. The 
complex modulus, G*, was determined at a constant strain (0.1%) for a frequency range of 0.1 to 
100 rad/s. The stable plateau modulus, at frequencies between 0.1 and 10 rad/s, was used to 
approximate the equilibrium modulus, G, according to a previous study.63 
2.3.2.3 Morphological study of C-A 
 The morphological structure of the hydrogels before and after basic buffer rinsing was 
directly imaged using a light microscope (Nikon Eclipse Ti, Japan) at a magnification of 100X. 
Then the samples were freeze-dried, sputter-coated with gold and imaged using a SEM (LEO 
1525, Germany). 
2.3.2.4 Primary cortical neuron culture on C-A  
 Cortical neurons were obtained from 9-day old chicken embryos. Forebrains of the 
embryo were dissected, minced into small pieces, and enzymatically dissociated with 0.25% 
trypsin in PBS for 20 min at 37 °C, followed by inactivation with medium containing 10% fetal 
bovine serum (FBS, Invitrogen). A cell pellet was obtained after a brief centrifugation, and 
mechanical trituration using a fire-polished Pasteur pipette was applied to further dissociate the 
cells. Cells were then preplated on a collagen-coated petri dish and incubated for 1 h at 37 °C in 
a 5% CO2 atmosphere. Purified neuronal cells were collected and re-suspended for cell culture.  
 After counting, cells were seeded on sterile hydrogels with a density of 2×104 cells/cm2, 
and cultured in Dulbecco’s modified Eagle’s medium supplemented with 10% FBS, 1% 
penicillin/streptomycin and 1% L-glutamine at 37 °C in a 5% CO2 atmosphere for a 
predetermined time as specified in the following section. Nerve growth factor (NGF) is not 
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required to induce chick cortical neuron differentiation and neurite outgrowth.67 Therefore, NGF 
was not used in the cortical cell culture. Each of the hydrogel compositions was tested three 
times, meaning that each hydrogel was subjected to cultures on three separate days. 
2.3.2.5 Neuron adhesion on C-A  
 At the end of 3-day culture, cells were live stained with 0.05 v/v Calcein AM (Invitrogen) 
solution in PBS, and incubated at 37 °C in a 5% CO2 atmosphere for 30 min. Samples were 
rinsed twice with PBS before and after fluorescence staining. Fluorescent images were taken 
using a 10X objective lens on a confocal microscope (Leica SP2, Germany). Neuron adhesion on 
the hydrogels was assessed by counting cell density (cells/cm2).   
2.3.2.6 Neurite extension on C-A  
 For neurite extension quantification, a cellular process being equal to or greater than 25 
μm is defined as a neurite. The length of the longest neurite per neuron was used to analyze the 
percentage of neurons with different neurite outgrowth (25 – 50 μm, 50 – 150 μm, and >150 μm) 
on three representative areas for each 3-day cell culture sample.  
2.3.2.7 Neuron morphology on C-A 
 Neuron morphology was analyzed for 5-day cell cultures following the same live staining 
procedure as describe above. The samples were imaged on the confocal microscope. The 
network of neurons was imaged at with a 10X lens, and detailed morphological images of 
representative cells were captured with a higher power lens (63X). In order to correlate the 
observed neuron morphology with the structure of various C-A hydrogels, surface features of the 
gels obtained from the light microscopy images were simulated by distributing different 
percentages of random dots (1 unit, representing the chitosan component) in a blank area (100 x 
100 units, representing the agarose matrix) using a Matlab program. 
2.3.2.8 Statistics 
 Data were analyzed using analysis of variance (ANOVA, SAS 2008), and least squares 
means were compared by Tukey’s test. Differences were accepted at a significant difference 
value of p < 0.05. All data were reported as the mean ± standard deviation.  
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2.3.3 Results & Discussion 
2.3.3.1 Rheological study of C-A 
 Recent work has demonstrated that the stiffness of substrates influenced the adhesion and 
morphology of tissue cells,68, 69 and softer substrates were more favorable at facilitating neuronal 
differentiation than harder ones.20 As one of the key features of agarose gel for nerve repair lies 
in its close mechanical matching with the neural tissue, it is important that such feature is not 
compromised with the blend of chitosan. Although the introduction of chitosan slightly 
decreased the value of G (plain agarose hydrogel: ~75 Pa; C-A hydrogels: 20 ~ 70 Pa), the 
stiffness of the C-A hydrogels were still on the order of 100 Pa (Fig. 2.3), which is very close to 
the stiffness of the brain tissue.70 Therefore, from the mechanical property perspective, all of the 
C-A hydrogels are comparable to plain agarose and should have similar influence on neuronal 
growth.  
 The cause of slight reduction in the stiffness of the 0.33% C-A hydrogel is unclear. Clark 
et al.71 have reported similar observation in the agar/gelatin co-gels, where the shear modulus of 
the gel first falls as gelatin is added and then increases again with more addition of gelatin. The 
authors attributed the minima to the interference effect, i.e., the concentrating action of the 
gelatin aggregation is insufficient to increase the gel strength of the initially formed agar phase to 
match the value of a pure agar gel until the gelatin concentration reaches beyond the phase 
inversion point. We speculate the chitosan molecule has similar interference effect on agarose in 
our hydrogel system, but the exact mechanism is beyond the scope of this study. 
2.3.3.2 Morphological study of C-A  
 All non-rinsed C-A hydrogels were as clear as the plain agarose gel (not shown), but they 
displayed an opaque appearance after neutralization (Fig. 2.4 (a)). The extent of the opacity 
directly corresponds to increasing concentrations of chitosan. Light microscope images show 
aggregates within the agarose matrix (Fig. 2.4 (b)). A correlation between the density of 
aggregates and concentration of chitosan was observed too. The morphology of samples was also 
investigated using SEM. C-A hydrogel with 3.0 wt% of chitosan collapsed during sample 
preparation, thus images are not available for this composition. As shown in Fig. 2.5, plain 
agarose hydrogel and non-rinsed C-A hydrogels display opened porous structure, while rinsed C- 
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Figure 2.3 Equilibrium modulus G versus chitosan concentration: The stiffness of brain, skeletal muscle, 
and cartilage are presented for comparison.70  
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Figure 2.4  Photograph and light microscope images of hydrogels: (a) Photographs demonstrating the 
opaque appearance of C-A hydrogels compared with plain agarose gel and (b) light microscope images 
(100X) showing the structure of hydrogels. Concentration of chitosan from top to bottom: 0% (plain 





Figure 2.5 SEM microscope images showing the structure of hydrogels: (a) plain agarose; C-A hydrogels 
before and after neutralization: (b & e) 0.33%, (c & f) 1.0% and (d & g) 2.0%. 100X: scale bar = 200 μm; 
4000X: scale bar = 5 μm. 
100X     4000X 
            





Figure 2.5 continued. 
100X     4000X 
   
     after rinse
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A hydrogels form partially or fully closed structure. Higher magnification images (4000X) reveal 
a relatively smooth structure for non-rinsed C-A hydrogels and grainy structure for rinsed 
samples. 
 These observations can be attributed to the phase separation of chitosan in the neutralized 
hydrogels (Fig. 2.6). Briefly, the chitosan used in this study is only soluble in acidic solutions 
(pH  <  6.5) due to the electrostatic effect among the protonated amine groups along the polymer 
chains.2 Under this condition, the C-A hydrogel forms a homogeneous phase with extended 
chitosan chains within the agarose matrix and displays a clear appearance. The electrostatic 
effect, however, is diminished in neutral environments because most of the amine groups are 
deprotonated when pH values approach 7.4.72 Therefore, the extended chitosan chains contract 
after neutralization, and aggregates of chitosan precipitated within the agarose matrix, resulting 
in the phase separation.3 We have observed with a light microscope a uniform distribution of the 
chitosan aggregates throughout the entire depth of the gel, indicating a well-dispersed precipitate. 
It is also worth noting that the size of the chitosan aggregates (average estimated diameter of 1 
μm from SEM images) did not change much as the concentration of chitosan increased. The 
apparent increase in opacity and the number of aggregates could be accounted for by the higher 
concentration of chitosan. 
2.3.3.3 Neuron adhesion on C-A 
 There was a significant difference in the number of live cells between hydrogels with and 
without chitosan. All of the C-A hydrogels showed better support of neuron adhesion than the 
plain agarose hydrogel (Fig. 2.7). As mentioned earlier, this difference is most likely due to the 
ability of chitosan chains to interact with the cell membrane by electrostatic effect. Similar 
results have also been reported for other types of cells, indicating a nonspecific interaction. It is 
quite difficult to measure the surface potential of the hydrogels due to their low stiffness. 
However, previous studies have already shown that even though most of the amine groups are 
deprotonated in a neutral environment, there are still positive charges on the surface of 
neutralized chitosan films49 and microspheres13.  
 Since chitosan can enhance the adhesion of neurons, one would expect a simple linear 
relationship between the cell density and the chitosan concentration in the hydrogel. However,  
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Figure 2.6 Schematic of phase separation of C-A hydrogel as a result of neutralization. Corresponding 
chemical structure change of chitosan due to the pH change of the solvent is also given. 
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Figure 2.7 Cell density versus chitosan concentration in C-A hydrogels. Error bar = standard deviation (n 
= 3, *p < 0.05). 
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this is far from the case. There was no significant difference in the cell density on the C-A 
hydrogels within the concentration range of chitosan in this study, except the 3.0% C-A 
composition (Fig. 2.7). Considering the size of the cell body (~15 μm) and chitosan aggregates 
(~1 μm), it is reasonable to conclude that a single cell can interact with several chitosan 
aggregates at the same time, and as long as sufficient chitosan is added, the change of chitosan 
concentration would not influence the total number of cells attached on the substrates. This 
observation is similar to studies demonstrating a surface cell-adhesive RGD ligand density 
threshold, where increases in the RGD density did not significantly affect the number of cells 
attached, suggesting a saturation of receptor-ligand bonds at higher ligand density.73 The number 
of neurons attached on the 3.0% C-A gel is statistically lower than the rest of C-A compositions. 
It could be due to the fact that the gel supported relatively poorer neurite development (as 
discussed next) and therefore, a portion of the loosely adhered neurons died during culture or lost 
during the staining process. 
2.3.3.4 Neurite extension on C-A  
 For a substrate to be effective as a scaffold for neural tissue engineering, it should not 
only support neuron adhesion, but also support neurite extension. Neurites are very important 
projections of a neuron, as they will lead to the eventual formation of functional neural network 
and enable synaptic transmission. It is therefore essential to examine how the C-A hydrogels 
affect neurite outgrowth. Significant differences were observed for the ability of neurons to 
develop neurites on different C-A hydrogels (Fig. 2.8). The percentages of cells that could 
develop neurites longer than 50 μm (50-150 μm & >150 μm) after a 3-day culture on 3.0% C-A 
gels were much lower than the others, and 2.0% formulation also lacked the ability to support 
very long neurites (>150 μm). Such inhibition effect from substrates fabricated to facilitate 
neurite extension has been observed in an earlier study on polylysine-functionalized chitosan 
hydrogels.6 Crompton et al. found that immobilized poly-D-lysine (PDL) improved cell survival 
up to an optimum concentration of 0.1%, and further increases of PDL resulted in a decrease in 
cell number and neurite outgrowth. The authors attributed this result to the strong interaction of 
cells with PDL in their 3D gel. We are proposing an alternative hypothesis to explain the 
phenomenon observed in the present study. Our hypothesis is based on our observations from  
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Figure 2.8 Percentages of neurons with different lengths of neurite versus chitosan concentration. 
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neuron differentiation and morphology study, which will be further discussed in the following 
section. 
2.3.3.5 Neuron morphology on C-A  
 Neurons on all C-A hydrogels exhibited a 3D profile, as shown from the confocal images 
where the cell body of the neuron situated at the surface of the gel and the neurites were seen 
extending into the gel towards the bottom (Fig. 2.9 & Fig. 2.10). It indicated that the neurite-
permissive property of the agarose scaffold was preserved despite the addition of chitosan. 
However, cells on C-A hydrogels with lower chitosan concentration (0.33%, Fig. 2.10 (a)) 
tended to extend axons, typically the longest neurites, as a straight line without obvious 
branching. Their counterparts on denser gels (1.0%-3.0%) favored tortuous axon morphology 
with extensive branches (Fig. 2.10 (b) – (d)). This trend can also be seen on the confocal images 
showing the overall feature of the network, although the fine structure of the neurites was not 
visible under such low magnification (Fig. 2.9). Data for 0.66% and 1.5% C-A hydrogels were 
not shown as the neurons on these two compositions exhibited similar properties as the 1.0% 
formulation.   
 Why do neurons behave so differently on the simple blends of chitosan and agarose? In 
order to answer this question, neuron differentiation was “simulated”, by hand, in two-
dimensional (2D) mimic structures of different C-A hydrogels (Fig. 2.11). The basis for this 
simulation is the observation that chitosan aggregates in these C-A hydrogels are relatively 
uniform in size (~1 μm) and randomly distributed (Fig. 2.4 (b)). Briefly, different percentages of 
random dots (1 unit) in a blank area (100×100 units), corresponding to different chitosan 
concentrations, were generated using Matlab. Neurites can only pass through the white area, 
which represents the permissive agarose matrix. However, attaching a black dot (chitosan 
aggregate) at each step is necessary for neurite extension. The distance between two steps must 
be shorter than 6 units (6 μm), which is the reported critical bridge distance for the growth cone 
at the end of an axon to migrate.74 Branching is preferable when the neurite has to make a sharp 
turn. Although the “simulation” work was done in a 2D manner, the results shared quite similar 




Figure 2.9 Confocal images of the neuron network on C-A. The highest depth neurites could reach is 160 
μm below the surface according to our observations. Scale bar = 300 μm.  
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Figure 2.10 Representative images showing neuron morphology on C-A. Color band indicates the depth 
of the neurite location. Scale bar = 50 μm. 
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Figure 2.11 ”Simulation” of neurite differentiations: simulated by hand on substrates mimicking the 
hydrogels using random dots generated by Matlab. 
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two-fold functions of chitosan aggregates during neuron differentiation: “adhesion sites” and 
“steric hindrances”.  
 On the one hand, the positive charges on the chitosan aggregates support neurite 
attachment during differentiation. According to the study by Clark et al.,74 the distance between 
two attachment sites needs to be less than 6 μm to guarantee a successful forward procession for 
growth cones. Because even the hydrogel with the lowest concentration of chitosan (0.33%) is 
able to support neurons to develop fairly long neurites, it is reasonable to conclude that all of the 
concentrations of chitosan are sufficient for satisfying the minimum gap distance for the growth 
cone to move forward. Light microscopy images also show such a network with a comparable 
inter-aggregate distance (Fig. 2.4 (b)).  
 On the other hand, the chitosan aggregates are formed by highly contracted polymer 
chains, so it is not easy for neurites to penetrate these dense areas. When growth cones meet such 
a “roadblock”, it is more favorable for them to make a turn and/or branch out to continue their 
pathfinding. The more concentrated the C-A hydrogel, the higher possibility for the growth cone 
to encounter a hindrance and make turns and branches. These side branches of neurites, also 
known as collaterals, are quite favorable because they can form points of contact with 
appropriate target neurons and provide more chances for signal transmission among neural cells. 
However, the continuing increase of the chitosan concentration could have its drawbacks, 
causing the chitosan aggregates to block neuronal outgrowth. We thus hypothesize that it is this 
steric hindrance effect that caused the 3.0% C-A hydrogel to perform poorly for neurite 
extension even though it should have the most attachment sites for neurons. 
 The two functions of chitosan play very important roles in enhancing neuron attachment 
and guiding neurons to develop multi-branching neurites in a 3D manner, resulting in the 
formation of a more extensive network and better communication among neural cells (Fig. 2.9). 
The C-A hydrogel, taking advantage of the permissive structure of agarose hydrogels and the 
two-fold properties of chitosan, can be a promising tissue scaffold for brain injury repair. Based 
on our study, the optimum concentration of chitosan in the agarose gel is 0.66-1.5 wt%, which 
supports more cells with longer neurites and better neural network compared with the other 
compositions (Fig. 2.8 & Fig. 2.9). 
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 Although a few studies have previously reported that high substrate density can inhibit 
nerve growth,75, 76 our work is the first one to demonstrate such an inhibition effect by correlating 
the morphology of single cells and a 3D structured tissue scaffold. This hypothesis not only 
explains our observations in the cell culture study, but also helps us better understand the 
mechanism by which a neurite extends or branches. 
2.4 Conclusions & Significance 
 A simply prepared C-A hydrogel system was developed for TBI repair. The stiffness of 
the C-A hydrogels was very similar to the brain tissue, providing a mechanically compatible 
environment for neuron growth. The agarose matrix presented a permissive structure for neuron 
growth, and its incapacity for neuron adhesion was complemented by the addition of chitosan. 
More importantly, a novel hypothesis on the “steric hindrance” effect of chitosan on neurite 
outgrowth was proposed based on our observations. It implies that a proper adjustment of the 
chitosan concentration could directly impact the morphological development of neurons, and 
could be used as a simple yet versatile approach to obtain desirable neuronal structures.  This 
hydrogel system and its multi-functionality allow for applications of simply prepared agarose-
based hydrogels for neural tissue repair. 
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CHAPTER III 
GRAPHENE-CHITOSAN NANOCOMPOSITES FOR 
NEUROPROSTHETICS 
 A manuscript presenting part of the data in this chapter has been submitted to Nano 
Letters for review in March of 2010 [Zheng Cao, Yongchao Si, Craig Cavanaugh, Wei He. 
Graphene-chitosan nanocomposite for neural interface applications]. Submitted data include: 
Fig. 3.2, Fig. 3.3, Fig. 3.4 (a, e and f), Fig. 3.5, Fig. 3.6, Fig. 3.7, and Fig. 3.8 (a, c, e and f). 
Section 3.1, 3.2.3 and 3.3 are mostly cited from the submitted manuscript with a few 
modifications. Section 3.2.1 and 3.2.2 are newly written.  
 The first author (Zheng Cao) finished all of the experiments in this study. The fourth and 
corresponding author (Dr. Wei He) is advisor of Zheng Cao and financially supported this work. 
The second author (Dr. Yongchao Si) and (Dr. Craig Cavanaugh) are collaborators of Dr. Wei 
He, and provided the graphene solution and professional advice for this work. 
3.1 Introduction 
 Successful interfacing with neural tissue holds enormous potential for both fundamental 
neuroscience research and clinical treatment of neurological diseases or injury.77-82 A key 
component of this application is the implantation of the device in neural tissue to exchange 
information with local population of neurons. Currently, these implantable devices suffer from 
large variability and limited longevity in performance, which is one of the major bottlenecks for 
neural interface technology.78, 79, 82 To address this challenge, the neural interface community is 
exploring novel implantable materials.48 In this study, we rationalize that graphene-based 
materials could potentially be used for implantable neural devices.  
 Graphene (G), a 2-D monolayer of carbon atoms covalently-bonded in a hexagonal array, 
is being intensively studied since the discovery of processes enabling the exfoliation of G into its 
free-standing form.83 Its excellent properties, including high values of electrical conductivity,84 
thermal conductivity,85 and specific area,86 make it a promising candidate in a variety of 
applications, such as energy storage materials,86 polymer composites,87, 88 liquid crystal 
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devices,89 etc. Unlike carbon nanotubes (CNTs), its sibling in the family of carbon materials, 
very limited study has been reported on the applications of graphene in biomedical fields.90, 91 
Use of CNTs for biomedical applications, particularly those involving placement inside the body, 
faces a toxicity issue. Studies have reported that CNTs may insert themselves between the lipid 
bilayer of cell membrane, leading to membrane disruption and cell death.92-95 Toxicity issues 
also arise from the intrinsic impurities from the catalysts used for CNT production.96-98 Although 
graphene sheets are ultra-thin (~1 nm), a relatively large lateral size (several micrometers) on the 
2D plane is achievable.99 This could result in less size-induced toxicity than CNTs. Furthermore, 
graphene production is less plagued with impurity issues,100 which benefits biomedical 
applications.   
 Currently, four methods have been used to prepare graphene: chemical vapor deposition 
(CVD) and epitaxial growth, micromechanical exfoliation of graphite, epitaxial growth on 
electrically insulating surfaces, and creation of colloidal suspensions.100 Among these methods, 
production of graphene from colloidal suspensions is the most scalable and versatile approach. 
This allows for potential mass production and a variety of chemical functionalizations. Typically, 
graphene cannot be easily dispersed in water, which is the most preferred solvent for biomedical 
applications. This challenge has been addressed by the development of water soluble graphene 
with the introduction of sulfonate groups, which can be readily dispersed in water at reasonable 
concentrations (2 mg/mL) with its electrical conductivity preserved.99 It provides an opportunity 
to explore the biomedical potentials of graphene. 
 Graphene is non-biodegradable, thus suitable for long-term in vivo applications. It is also 
electrically conductive, thus able to provide a communication platform with neurons. To improve 
its interaction with neurons, we complemented graphene with chitosan (C), to form a 
nanocomposite. Results from Chapter II have shown that inclusion of chitosan can significantly 
improve neuron adhesion to substrates. In this chapter, graphene-chitosan (G-C) nanocomposites 
were prepared and characterized for properties pertinent to neural interface applications. 
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3.2 G-C Nanocomposites for Neuroprosthetics 
3.2.1 Rationales 
 This section briefly introduces the rationales behind the experimental design and special 
techniques used in this chapter. Please see section 3.2.2 Experiments for detailed experiments. 
3.2.1.1 Sample preparation 
 The concentration of chitosan is the only variable in sample preparation. A stock chitosan 
solution was prepared first, and added into graphene later. A graphene stock solution (0.5 mg/mL 
in DI water) was directly provided by our collaborator Dr. Craig Cavanaugh and Dr. Yongchao 
Si from University of North Carolina at Chapel Hill. A consistent graphene concentration (0.4 
mg/mL) was maintained for all the G-C solutions. Although both coatings and free standing 
films can be prepared by air evaporation of the G-C solution, G-C coatings on glass will be used 
for most of the study due to its ease of preparation and handling. These experiments include: 
electrical property, surface morphology and topography, neuron adhesion, and neuron 
morphology. 
 The flexibility of G-C was examined by rolling the free standing film up. An insertion 
test was done to show its feasibility for surgical implantation. 
3.2.1.2 Sample characterization 
 The remarkable electrical conductivity of graphene is one of the main rationales behind 
this study. Because chitosan is non-conductive, the electrical property of G-C needs to be 
confirmed first. The electrical resistance of G-C was measured using a multimeter.  
 The surface topographical features can have great influence on cell adhesion and 
growth.101 Therefore, two methods (SEM and AFM) were selected in this chapter to characterize 
the surface structure of G-C samples. Typically SEM can only detect information at the micro-
scale due to its limited magnification, but a large area could be scanned at one time. AFM, on the 
other hand, could provide nano-scale information but with a relatively small scanning area. 
Results from these two methods could give us a comprehensive idea about the structural 
properties of the sample surface. The roughness of the surface can also be calculated using the 
software provided by the AFM vendor. 
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3.2.1.3 Biocompatibility of G 
 Good biocompatibility is one of the most critical features that a biomaterial should 
possess. As mentioned earlier, graphene could have lower cytotoxicity due to its large lateral size 
on the 2D plane. Typically there are two ways to evaluate the biocompatibility of a film 
substrate. One way is directly seeding cells on the fabricated substrate and assessing the cell 
viability after culture. Another way is culturing cells on a good substrate using growth medium 
supplemented with the raw material used for the substrate fabrication. The second method was 
applied in this study because it can reflect the toxicity of single graphene sheets on cells. 
 To compare our results with a previous work studying the cytotoxicity of CNTs,98 we 
employed a fibroblast cell line (NIH 3T3) in this study. A relatively high treatment concentration 
(25 μg/mL) was selected for the culture. Besides, a neuron cell line (N2a) was also used for 
cytotoxicity study, since this study is designed for neural engineering applications. 
3.2.1.4 Neuron responses to substrates 
 Since this G-C nanocomposites system is newly developed, both cell line (N2a) and 
primary cortical neurons were used for neuron adhesion study. Due to their different 
characteristics, different culture times were employed. Because N2a can attach easily on many 
substrates and proliferate quickly in serum-supplemented medium, a relative short culture period 
(4-hour) was chosen for culture. On the contrary primary cortical neurons only attach on 
specially treated substrate and don’t proliferate during culture, a longer culture period was used. 
A poly-L-lysine (PLL) coating on glass was used as a positive control. All cell adhesion data 
were normalized as percentages to PLL. 
 Like the C-A hydrogel study, neurite outgrowth was also evaluated for primary culture. A 
different technique was used here for the following reasons. The highest magnification lens of 
the confocal microscope used in this study is 63X, with which we cannot see much detail related 
to the interaction between neurons and the substrate. Because the G-C coatings are dark in 
appearance, a conventional inverted light microscope cannot be used for observation. SEM 
imaging, due to its high magnification and easy imaging on sample surfaces, was used for neuron 
morphology characterization in this study. Because the glass supported G-C coatings are dry and 
rigid, SEM fixation is feasible. The reason that we did not use this method for the hydrogel study 
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is because there is a concern about the dehydration process in the SEM fixation, which may 
destroy the hydrogel structure and the interaction between the cells and substrate. Because cells 
are not conductive, a gold sputter coating needs to be applied on the samples before imaging. 
3.2.2 Experiments 
3.2.2.1 Preparation of G-C 
 Chitosan was firstly dissolved in a 2.0 wt% acetic acid solution to a final concentration of 
16 mg/mL. A series of G-C solutions (weight ratio: 1:0, 1:0.5, 1:1, 1:4 and 1:8) were prepared 
with graphene suspension (0.5 mg/mL, Allotropica Technologies), DI water and the chitosan 
stock solution. A consistent graphene concentration (0.4 mg/mL) was maintained for all 
formulations. Table 3.1 shows the formulations for all samples prepared.  
 Stability of the G-C dispersions was examined by visual inspection after 24 h of sitting. 
Supported G-C nanocomposite films were prepared by evaporation on glass. Briefly, 100 μl 
dispersion of G-C was casted on substrates and allowed slow evaporation overnight at room 
temperature. Thin free standing G-C films were prepared on poly(dimethyl siloxane) (PDMS) in 
the same way, except larger volume of dispersions were used. 
3.2.2.2 Electrical property of G-C 
 The resistance of both plain graphene (PG) and G-C composite films was measured using 
a multimeter (Resistivity Meter SRM-232, Guardian Manufacturing Inc.) to determine if the 
electrical characteristic of graphene is lost after the addition of chitosan, a non-conductive 
polymer. 
3.2.2.3 Surface morphology and topography of G-C 
 The surface and cross-sectional structure of the nanocomposite films was characterized 
with SEM. Atomic force microscope (Agilent AFM 5500) measurement was performed in 
contact mode for nano-scale characterization on the surface of uniform films. Both average and 
root mean square roughness can be calculated using the customized software of the AFM. 
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Table 3.1 Formulations for G-C Nanocomposites 
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3.2.2.4 Cytotoxicity of G 
 Culture medium for NIH 3T3 is Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with 10% Hyclone FetalClone III (Thermo Scientific), 1% penicillin/streptomycin 
(P/S) and 1% L-glutamine. Medium for N2a culture DMEM supplemented with 10% fetal 
bovine serum (FBS), 1% P/S, and 1% L-glutamine. Cells were seeded on 48-well plates (1×104 
cells/cm2) and cultured in medium. After a 4-hour incubation at 37 °C in a humidified 5% 
CO2/95% air atmosphere, half of the cultures was treated with graphene solution to a final 
concentration of 25 μg/mL.98 The cells were cultured for another two days. Then the viability of 
cells was characterized using WST-1 assay (Roche) following the recommended procedure by 
the manufacturer. The absorbance was measured using an ELISA plate reader at 450 nm.  
3.2.2.5 Neuron adhesion on G-C 
 As N2a can attach easily on many substrates and proliferate soon in serum-supplemented 
medium, a relative short culture period (4-hour) was chosen for culture (seeding density: 4×104 
cells/cm2). Primary cortical neurons were harvested from 9-day-old chicken following the 
procedure described earlier (section 2.3.2.4 Primary cortical neuron culture on C-A). Because 
primary cortical neurons do not proliferate, a 5-day culture was used for both cell adhesion and 
morphology study (seeding density: 2×104 cells/cm2).  
  At the end of the cultures, cells were live stained with 0.05 v/v Calcein AM solution in 
PBS and incubated at 37 °C for 20 min. Samples were rinsed twice with PBS before and after 
fluorescence staining. Fluorescence images were taken using the confocal microscope. Neuron 
adhesion on the substrates was assessed by counting cell number using Image J. The results were 
expressed as percentage to the PLL positive control.  
3.2.2.6 Neuron morphology on G-C 
 Primary cortical neuron was cultured for neuron morphology study. After the fluorescent 
imaging, cultures were fixed and dehydrated. Briefly, cells were washed twice with 0.1 M 
Millonig’s phosphate buffer (Electron Microscopy Sciences), followed by primary fixation with 
3% glutaraldehyde (Electron Microscopy Sciences) in the same buffer for 1 hour at room 
temperature. Then cells were rinsed with buffer for 3 times (10 min each). Secondary fixation 
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was performed for 30 min with 1% osmium tetroxide (Electron Microscopy Sciences). Cell 
dehydration was carried out using ascending grades of ethanol (25%, 50%, 75%, 95%, 100%, 
and 100%) for 10 min at each grade. Subsequently, samples were immersed in the mixtures of 
ethanol and hexamethyldisilazane (HMDS) with a descending order of ratio (ethanol: HMDS = 
2:1, 1:1, and 1:2), followed by 100% HMDS dehydration twice for 10 min each. Samples were 
vacuum dried and kept in a desiccator to ensure a complete evaporation of HMDS. For imaging, 
samples were mounted on aluminum stumps, coated with gold in a sputtering device, and 
examined by SEM. 
3.2.2.7 Statistics 
 The same technique as described in section 2.3.2.8 Statistics was used for statistical 
analysis. 
3.2.3 Results & Discussion 
3.2.3.1 Preparation of G-C  
 A prerequisite for the preparation of a uniform film is an even dispersion of the source 
solution. As shown in Fig. 3.1 (a), solutions of plain graphene (PG), G-C composites with 
graphene to chitosan ratios of 1:4 (G1C4) and 1:8 (G1C8) were stable and well-dispersed after 1 
day or longer, while G-C composite with graphene to chitosan ratio of 1:0.5 (G1C0.5) and 1:1 
(G1C1) precipitated at the same time point.  Obvious aggregates were observed right after the 
mixing of graphene and chitosan solution for G1C1.It has been suggested that the repulsive 
electrostatic force between the negatively charged graphene sheets (Fig. 3.2) accounts for the 
stability of the PG dispersion.99 In this case, the introduction of positively charged chitosan 
solution likely neutralized the negative charges on graphene, resulting in the collapse of the 
graphene dispersion (G1C1). When less chitosan is added, the graphene is not totally neutralized, 
resulting in a partially precipitated solution (G1C0.5) (Fig. 3.1 (b)). When additional chitosan is 
added, the final solution becomes well-dispersed again (G1C4 and G1C8), most likely due to the 
positive charge from the excess chitosan. The exact mechanism underlying the interactions 
between graphene sheets and molecular chains of chitosan is yet to be elucidated, but we did 
notice a darker appearance for G1C8 compared with other compositions, even though all samples  
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Figure 3.1 Photograph of G-C dispersions: (a) at various ratios of graphene to chitosan; (b) partially 




Figure 3.2 Chemical structure of chitosan and water soluble graphene. 
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should have the same amount of graphene (Fig. 3.1 (c) & (d)). It would be informative to 
uncover the microstructures of the components in the G-C solutions in future studies.  
 A free standing film was prepared by evaporating G1C4 solution on a PDMS block. The 
films can be easily peeled off the PDMS and rolled up (Fig. 3.3 (a) - (c)), demonstrating good 
flexibility. This is a desirable feature for implantable neural prosthesis.102, 103 It was also 
confirmed that the G-C films are mechanically strong enough for insertion, by testing with an 
agarose gel mimicking brain tissue (Fig. 3.3 (d)). 
3.2.3.2 Electrical property of G-C 
 The G-C films remained electrically conductive, with resistance lower than that of a 
silicon wafer (Table 3.2). As expected, the G-C nanocomposites were less conductive than the 
PG, and the more chitosan in the composite, the higher the resistance. The ability of graphene to 
impart electrical properties to non-conducting polymer is consistent with previous reports of 
electrically conductive polystyrene-graphene composite material.87 Though we demonstrated that 
the G-C nanocomposites can be electroactive, the G : C ratio in the nanocomposite requires 
further optimization in order to achieve an electrical property suitable for neural interfacing. 
3.2.3.3 Surface morphology and topography of G-C 
 Surface properties play critical roles for biomaterials. Specifically, surface morphology 
directly impacts cellular interactions with the biomaterial. Scanning electron microscope (SEM) 
images show the surface morphology of the supported films and the cross-section structure of a 
free-standing G1C8 film (Fig. 3.4). A drastic change in morphology can be seen between PG and 
G-C composites. While PG forms a smooth surface at the micro-scale (Fig. 3.4 (a)), G-C 
composites have a relatively rough surface (Fig. 3.4 (b) – (e)). Among G-C composites, the 
surfaces of G1C4 and G1C8 possess uniform grainy structure (Fig. 3.4 (d) & (e)), while G1C0.5 
and G1C1 display a surface feature between PG and G1C4 / G1C8 (Fig. 3.4 (b) & (c)). The 
cross-sectional image (Fig. 3.4 (f)) shows a continuous internal structure of the nanocomposite, 
suggesting good percolation of graphene in the nanocomposite. This enables graphene to exert its 
electrical functionality.  
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Figure 3.3 Photograph of free standing G-C films: (a) – (c) A free standing G-C nanocomposite films 
displays flexibility and ease of handling. (d) Insertion test of a free standing graphene-chitosan 
nanocomposite film with an agarose gel mimicking the brain tissue. 
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Table 3.2 Electrical resistance of plain graphene (PG), graphene-chitosan composites, and silicon wafer. 
Data shown as mean ± standard deviation.  
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Figure 3.4 SEM images showing the surface morphology of samples: (a) PG, (b) G1C0.5, (c) G1C1, (d) 
G1C4, (e) G1C8, and (f) the cross-sectional structure of a G1C8 free standing film. The way to prepare 
the cross section of G1C8 is illustrated on top-left of (f). Scale bar = 20 μm. 
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 Atomic force microscopy (AFM) was used to probe the surfaces of uniform films for 
calculation of roughness. Nano-scale features were observed on PG surface (Fig. 3.5 (a)), with 
an average root-mean-square roughness of 42 nm. Incorporation of chitosan notably increases 
the roughness to 137 nm (Fig. 3.5 (b)), resulting in a grainy surface.  It is interesting that this 
composite approach changed the nano-structured surface of graphene, which will have 
implications for subsequent cellular interactions. The topography of a silicon wafer was 
characterized for comparison (Fig. 3.5 (c)). 
3.2.3.4 Cytotoxicity of G  
 As mentioned earlier, cytotoxicity is one of the main concerns in the biomedical 
applications of CNT, especially for single-wall CNT (SWCNT). Based on their extensive study, 
Tian et al. attributed the toxic effect of SWCNT to its ultra-small dimensions.98 Since graphene 
sheets are two-dimensional materials with micro-scale lateral length, a lower cytotoxicity 
comparing to CNTs is possible. Compared to the reported 75% survival rate of human fibroblast 
cells (2-day treatment of SWCNT: 25 μg/mL),98 a 92.8% survival rate for the same type of cell 
(2-day treatment of graphene: 25 μg/mL) was observed in our study (Fig. 3.6). Graphene also 
showed high biocompatibility to neuron cells (N2a) with a 93.3% survival rate. The results 
suggest good cytocompatibility of graphene towards both fibroblasts and neurons and suitable 
for further investigation for neural interfaces. A recently published article also demonstrates a 
better biocompatibility of graphene compared with CNTs.91 
3.2.3.5 Neuronal responses to G-C 
 Besides electrical properties, good interaction between biomaterials and neurons is 
particularly desired for neural interface applications. Ideally, the material should support neuron 
adhesion and growth to ensure high fidelity and maximal signal communication between the 
implant and the nervous system. 
 For both the N2a neural cell line and primary chick cortical neurons, PG was not 
favorable for cell adhesion (Fig. 3.7), which could be attributed to the presence of negatively 
charged sulfonate groups on graphene (Fig. 3.2). However, some G-C nanocomposites showed 
much higher cell attachment (G1C4 for N2a; G1C4 and G1C8 for cortical neuron), suggesting 
that incorporation of amine-rich chitosan improves the material’s ability to support neuron  
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Figure 3.5 AFM images showing the surface topography of samples: (a) PG, (b) G1C8, and (c) silicon 
wafer. Scale bar = 20 μm. 
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Figure 3.6 Cytotoxicity of graphene (G) showing high survival rate of cells: fibroblast (NIH 3T3 92.8%) 
and neurons (N2a, 93.3%).  Cells were treated with 25 μg/mL of graphene (G+) for 2 days. Control 
sample without graphene treatment is noted as G (-). The survival rate of fibroblast (75%) with carbon 




Figure 3.7 Cell adhesion of N2a cell line and primary cortical neuron expressed as percentage to the 
poly(L-lysine) (PLL) positive control. N2a: G1C4 is significantly higher than other samples; Cortical 
neuron: G1C4 and G1C8 are significantly higher than other samples.  (n = 3, p < 0.05).  
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adhesion. The responses of N2a and cortical neuron to this series of G-C composites are slightly 
different. For example, it appears G1C1 supported more N2a cells, while G1C8 supported more 
cortical neuron. This observation could be attributed to the different characteristics of the two 
types of cells.  
 According to the results from cell adhesion study, the morphology of cortical neuron on 
PG, G1C4, and G1C8 were investigated by SEM. Extensive neurite-like structures were 
observed stemming from the body of cortical neurons attached on G-C nanocomposite (Fig. 3.8 
(a)). This suggests the potential ability of the G-C nanocomposites to induce neural 
differentiation. It appears as if the surface roughness of the G-C nanocomposites allows for 
extensive neurite formation (Fig 3.8 (b) – (d) arrows). The intimate contact between neurons 
and G-C surface is advantageous for neural interface applications. It can not only improve 
neuron adhesive strength to the implanted device and therefore minimize micromotion between 
the device and the tissue, but also promote signal transduction between the attached neuron and 
the device. This could lead to enhanced sensitivity of the device. Though PG in general is not 
pro-neural adhesion, those few cells that did attach were seen with neurite-like structures as well 
(Fig. 3.8 (e)). The morphology of neural processes was very different from those on the G-C 
surface. The neurites were much fewer in numbers, but they were longer and showed extensive 
branching (Fig. 3.8 (f)). It is as if the cells are trying to maximize the anchoring points with the 
relatively featureless surface. The long neurites are also beneficial for neural interface 
applications, as they will allow cell-cell communication. Studies have shown that both micro- 
and nano-scale topography of the substrates could have influence on cell migration, adhesion, 
differentiation, and morphology.104 Although the underlying mechanism remains elusive, the 
different topographic properties of PG and G-C nanocomposites could account for the different 
cell morphologies observed in this study. Both morphologies are intriguing and we are interested 
to further tune the G-C compositions to develop a material that can enable development of both 
types of neural processes for interfacing. 
3.3 Conclusions 
 We reported for the first time the development of a simple G-C nanocomposite system 
for potential neural interface applications. The G-C nanocomposites can be prepared both as  
  63
 
Figure 3.8 SEM images of primary cortical neuron growing on samples: (a-d) G1C8 and (e, f) PG films 
with different neurite-like structures (arrows). 
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coatings and flexible free-standing films simply from environmentally and biologically friendly 
aqueous dispersions of water soluble graphene and chitosan. The free standing films showed 
good flexibility and capability for insertion. The electrical conductivity of graphene was 
maintained in the composite system. Cytotoxicity study showed good biocompatibility of 
graphene towards both fibroblast and neuron. The bio-adhesive property of chitosan was 
reassured in this study. The morphology of the films was closely dependent on the composition, 
and directly influenced neuron adhesion and morphology. This biocompatible G-C 
nanocomposite system is poised for further development and investigation as a novel implantable 
material to advance neural interface technologies. It could also provide a new platform for in 





GENERAL CONCLUSIONS AND FUTURE PERSPECTIVES 
 The ability of chitosan to enhance neuron adhesion was confirmed by the two studies in 
Chapter II and Chapter III. In respect of the cell morphology, the influences from chitosan were 
mainly composition dependent:  
 For the C-A hydrogel system, chitosan was embedded in the scaffold matrix and served 
as anchorage points for neurite extension. An optimum concentration range of chitosan was 
found to induce the best neural network compared with other compositions. Neither too low nor 
too high composition of chitosan could support good neurite outgrowth. A “steric hindrance” 
effect was proposed to explain the observations, and could be used as a simple yet versatile 
approach to obtain desirable neuronal structures. 
 For the G-C nanocomposite film system, the introduction of chitosan affected neuron 
morphology in another way. A rougher surface with nano-scale features was found for G-C 
nanocomposite films compared with plain graphene film, likely due to the incorporation of 
chitosan. Neurons displayed totally different structures on these two types of substrates. The 
underlying mechanism for this observation is still elusive, but it implies the possibility to tune 
the topological features of the G-C nanocomposites by simply adjusting the chitosan 
composition, and eventually control the interaction between neuron and substrates. 
 To maximize the clinical potential of the C-A hydrogel system, it is important to improve 
the gelation condition near physiological value. It could be accomplished by either incorporating 
an enzymatically induced gelation mechanism or tweaking agarose gelation temperature to that 
near physiological value. Concerns over the slow degradation of agarose and chitosan can be 
addressed by introducing moieties that allow for controlled release of degradative enzymes 
without interfering with the function of the gel. Future studies can also include embedding 
clinically relevant, traumatized neurons prepared with techniques reported by vandenPol et al.105 
within the gel and investigating cell-gel interaction, cell-cell interaction, and cell migration in 
three dimensions. 
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 Although the study for G-C nanocomposites provides promising results, more in-depth 
works need to be done in the future. As implanted materials, the mechanical properties, of the 
film (e.g., contact stiffness, tensile strength, etc.) should be quantitatively measured and the 
biostability of the film needs to be determined under physiological conditions. The compositions 
and fabrications of free-standing films should also be optimized for the best neuron-material 
interaction. A study to determine the capability of G-C nanocomposite to electrically interface 
with neuron would be informative. Responses of other types of cells in the brain towards G-C 
films, such as astrocyte and microglia, should also be investigated. Finally, for practical 
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